Document is current
Any future updates will be listed below
-
Authors
Rodrigues, Lívia Munhoz
Maistro, Simone
Katayama, Maria Lucia Hirata
Rocha, Vinícius Marques
Lopez, Rossana Veronica Mendoza
Lopes, Edia Filomena di Tullio
Gonçalves, Fernanda Toledo
Fridman, Cintia
Serio, Pedro Adolpho de Menezes Pacheco
Barros, Luciana Rodrigues Carvalho
Leite, Luiz Antonio Senna
Segatelli, Vanderlei
Estevez-Diz, Maria del Pilar
Guindalini, Rodrigo Santa Cruz
Ribeiro Junior, Ulysses
Folgueira, Maria Aparecida Azevedo Koike
-
Funding
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/04712-9, 2018/04847-1)
CAPES
Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil (CNPq-308052/2022-6)
- License Information
-
More Information
Article History
Received: 6 May 2024
Accepted: 2 September 2024
First Online: 10 September 2024
Competing interests
: RSCG declares Stock and Other Ownership Interests: Mendelics Análise Genômica; Consulting or Advisory Role: AstraZeneca, MSD; Speakers’ Bureau: AstraZeneca, Roche, Gilead, GSK, MSD, BMS, Novartis, Pfizer, Daiichi Sankyo; Travel, Accommodations, Expense, Dais: AstraZeneca, Gilead, Daiichi Sankyo. All other authors do not have any conflict of interest.
